Potomac Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Potomac Health News.

Press releases published on September 23, 2026

8 hours ago

ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI Advisor

Indeterminate GlobeNewswire

8 hours ago

SOTIO Advances SOT106 with Dual FDA Designations, Further Positioning the Program as a Potential Best-in-Class ADC for Sarcoma

Indeterminate GlobeNewswire

8 hours ago

Annovis Announces Partnership with Weave Bio, AI Regulatory Platform, in Preparation of NDA for Buntanetap in Alzheimer’s Disease

Indeterminate GlobeNewswire

8 hours ago

Tempest Appoints Global Finance Leader Nancy Freda-Smith to Board of Directors

Indeterminate GlobeNewswire

8 hours ago

BioAro Launches AI-Assisted LONgevity+™ Bioactives in the U.S. and U.K.

Indeterminate GlobeNewswire

8 hours ago

PhAST Corp. Receives FDA Clearance for Rapid Antimicrobial Susceptibility Testing Directly From Positive Blood Cultures

Indeterminate GlobeNewswire

8 hours ago

Altimmune to Participate in Stifel Cardiometabolic Forum

Indeterminate GlobeNewswire

8 hours ago

Adaptyx Biosciences Granted FDA Breakthrough Device Designation For Its Continuous Cortisol Monitoring Technology and Is Accepted into FDA’s Total Product Life Cycle Advisory Program

Indeterminate GlobeNewswire

8 hours ago

Clearmind Enhances U.S. IP Presence with Publication of Three Patent Applications Covering LSD, Ketamine and Ibogaine Combinations

Indeterminate GlobeNewswire

9 hours ago

Acoramidis Demonstrates Real-World Benefit Versus Tafamidis in ATTR-CM, Reducing Risk of Clinical Worsening

Indeterminate GlobeNewswire

9 hours ago

Artelo Biosciences Files New Provisional Patent Application Covering ART27.13 for Obesity, Alone and in Combination with GLP-1 Receptor Agonists, Following Unexpected Nonclinical Findings

Indeterminate GlobeNewswire

9 hours ago

Entente Education Canada urges federal government to take steps to improve cash flow and tax fairness for seniors, caregiver support

Indeterminate GlobeNewswire

9 hours ago

Wave Life Sciences Initiates Phase 2a Combination Trial of WVE-007 (GalNAc-siRNA) with Tirzepatide for Obesity

Indeterminate GlobeNewswire

9 hours ago

Artiva Biotherapeutics Announces Oral Presentation of AlloNK® Clinical Data at the 17th International Symposium on Sjögren’s Disease

Indeterminate GlobeNewswire

9 hours ago

Biomea Fusion Announces Termination of Proposed Public Offering of Securities

Indeterminate GlobeNewswire

9 hours ago

AC Immune Reports Positive Safety & Immunogenicity at week-100 in Part 1 of VacSYn Phase 2 Trial of ACI-7104

Indeterminate GlobeNewswire

9 hours ago

Avalo Therapeutics to Present at the European Academy of Dermatology and Venereology (EADV) 2026 Congress

Indeterminate GlobeNewswire

9 hours ago

Lexeo Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum

Indeterminate GlobeNewswire

9 hours ago

Oruka Therapeutics Announces Positive Week 28 Data for ORKA-001 from the Ongoing EVERLAST-A Trial Showing Deepening of Responses Without Additional Dosing

Indeterminate GlobeNewswire

9 hours ago

Verano to Report Third Quarter 2026 Financial Results on October 29, 2026

Indeterminate GlobeNewswire